We are thrilled to announce a strategic funding with participation from IndieBio (SOSV), Arben Ventures, Draper Cygnus and GRIDX to accelerate adoption of ArgenTag’s Single-Cell Long-Read platform.

We are absolutely thrilled to see ArgenTag featured today on the Nasdaq billboard in Times Square! What a special moment and powerful recognition for our team. ArgenTag Featured on Nasdaq as a BioTools Innovator. This display celebrates the completion of the prestigious BioTools Innovator program. Being selected as one of 31 elite life science tools companies of the year, chosen from over 400 applicants worldwide, provides incredible validation of our technology and vision

The ArgenTag team participated in the PacBio Workshop for Single Cell Analyses at Cold Spring Harbor Laboratory. The ArgenTag team, from left to right: Dr. Elizabeth Tapia (CSO), Leandro Ciappina (CEO) and Dr. Sofia Lavista Llanos (Director of Process Development) at the PacBio workshop Single Cell Analyses at CSHL. Dr. Sofia Lavista Llanos (Director of Process Development) presented comparative results from our single-cell solution to a broad audience of scientists at the wo